Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
1.
Infection and Chemotherapy ; : 146-150, 2017.
Article in English | WPRIM | ID: wpr-105541

ABSTRACT

Henoch-Schönlein purpura (HSP) is a systemic vasculitis involving the small vessels with distinct clinical features. The etiology of HSP is diverse, and viral infection is one of the many predisposing factors. Cytomegalovirus (CMV) infection mostly affects immune-suppressed patients, but rarely patients with normal immunity can also be affected. Authors experienced a case of HSP patient, with underlying small-cell lung cancer (SCLC) with CMV duodenitis. This is a rare case of HSP diagnosed in SCLC patient with predisposing factor of CMV infection.


Subject(s)
Humans , Causality , Cytomegalovirus , Duodenitis , Lung Neoplasms , Purpura , Systemic Vasculitis
2.
Cancer Research and Treatment ; : 1389-1398, 2016.
Article in English | WPRIM | ID: wpr-205897

ABSTRACT

PURPOSE: Breast cancer treatment has progressed significantly over the past 20 years. However, knowledge regarding male breast cancer (MBC) is sparse because of its rarity. This study is an investigation of the clinicopathologic features, treatments, and clinical outcomes of MBC. MATERIALS AND METHODS: Clinical records of 59 MBC patients diagnosed during 1995-2014 from seven institutions in Korea were reviewed retrospectively. RESULTS: Over a 20-year period, MBC patients accounted for 0.98% among total breast cancer patients, and increased every 5 years. The median age of MBC patientswas 66 years (range, 24 to 87 years). Forty-three patients (73%) complained of a palpable breast mass initially. The median symptom duration was 5 months (range, 1 to 36 months). Mastectomy was performed in 96% of the patients. The most frequent histology was infiltrating ductal carcinoma (75%). Ninety-one percent of tumors (38/43) were estrogen receptor–positive, and 28% (11/40) showed epidermal growth factor receptor 2 (HER-2) overexpression. After curative surgery, 42% of patients (19/45) received adjuvant chemotherapy; 77% (27/35) received hormone therapy. Five out of ten patients with HER-2 overexpressing tumors did not receive adjuvant anti–HER-2 therapy, while two out of four patients with HER-2 overexpressing tumors received palliative trastuzumab for recurrent and metastatic disease. Letrozole was used for one patient in the palliative setting. The median overall survival durations were 7.2 years (range, 0.6 to 17.0 years) in patients with localized disease and 2.9 years (range, 0.6 to 4.3 years) in those with recurrent or metastatic disease. CONCLUSION: Anti–HER-2 and hormonal therapy, except tamoxifen, have been underutilized in Korean MBC patients compared to female breast cancer patients. With the development of precision medicine, active treatment with targeted agents should be applied. Further investigation of the unique pathobiology of MBC is clinically warranted.


Subject(s)
Female , Humans , Male , Male , Breast , Breast Neoplasms , Breast Neoplasms, Male , Carcinoma, Ductal , Chemotherapy, Adjuvant , Estrogens , Korea , Mastectomy , Precision Medicine , Prognosis , ErbB Receptors , Retrospective Studies , Tamoxifen , Trastuzumab
3.
Korean Journal of Medicine ; : 625-629, 2014.
Article in Korean | WPRIM | ID: wpr-140467

ABSTRACT

Hypokalemic periodic paralysis is a rare disorder characterized by sudden onset of weakness and low serum potassium levels. We report a case provoked by combination chemotherapy including prednisolone. A 23-yr-man, diagnosed with diffuse large B-cell lymphoma, received chemotherapy. He developed significant weakness in upper and lower extremities during chemotherapy, and his serum potassium level was 1.7 mmol/L. Potassium replacement restored the weakness. Further workup revealed that prednisolone had provoked hypokalemic paralysis. As prednisolone triggered an attack of hypokalemic periodic paralysis, it should be administered with caution, particularly in patients with periodic paralysis.


Subject(s)
Humans , Drug Therapy , Drug Therapy, Combination , Hypokalemic Periodic Paralysis , Lower Extremity , Lymphoma, B-Cell , Paralysis , Potassium , Prednisolone
4.
Korean Journal of Medicine ; : 625-629, 2014.
Article in Korean | WPRIM | ID: wpr-140466

ABSTRACT

Hypokalemic periodic paralysis is a rare disorder characterized by sudden onset of weakness and low serum potassium levels. We report a case provoked by combination chemotherapy including prednisolone. A 23-yr-man, diagnosed with diffuse large B-cell lymphoma, received chemotherapy. He developed significant weakness in upper and lower extremities during chemotherapy, and his serum potassium level was 1.7 mmol/L. Potassium replacement restored the weakness. Further workup revealed that prednisolone had provoked hypokalemic paralysis. As prednisolone triggered an attack of hypokalemic periodic paralysis, it should be administered with caution, particularly in patients with periodic paralysis.


Subject(s)
Humans , Drug Therapy , Drug Therapy, Combination , Hypokalemic Periodic Paralysis , Lower Extremity , Lymphoma, B-Cell , Paralysis , Potassium , Prednisolone
5.
Tuberculosis and Respiratory Diseases ; : 295-298, 2014.
Article in English | WPRIM | ID: wpr-107316

ABSTRACT

Pulmonary systemic arterialization to normal basal lung without sequestration is a rare congenital anomaly. In this rare abnormality, arterialization of the left lower lobe is the most common type. In general, surgical treatments have been performed. Recently, for reducing the complications and risks of surgery, embolization is mainly attempted by using coils. We report a case of 22-year-old male patient with a 10 mm anomalous arterial supply to his normal lung, which is being successfully treated by transcatheter embolization when using the Amplatzer Vascular Plug that has been adapted for the treatment of high-flows and large artery occlusions.


Subject(s)
Humans , Male , Young Adult , Arteries , Embolization, Therapeutic , Lung , Pulmonary Artery , Respiratory System Abnormalities
6.
Cancer Research and Treatment ; : 204-207, 2014.
Article in English | WPRIM | ID: wpr-106239

ABSTRACT

Development of tumor lysis syndrome (TLS) may occur after chemotherapy or spontaneously in bulky or rapidly growing tumors. This syndrome is frequent but preventable in patients with hematologic malignancies. TLS following therapy has been reported infrequently in various types of solid tumors. TLS associated with oxaliplatin containing chemotherapy in a solid tumor has never been reported. A 59-year-old man received 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX) chemotherapy for metastatic colon cancer. Development of TLS occurred three days after administration of chemotherapy. Two days later, his abnormal laboratory findings were recovered with appropriate management. To the best of our knowledge, the current case is the first report on development of acute TLS following oxaliplatin containing chemotherapy in a patient with colon cancer. We also review the literature on tumor lysis syndrome in patients with colorectal cancer.


Subject(s)
Humans , Middle Aged , Colon , Colonic Neoplasms , Colorectal Neoplasms , Drug Therapy , Fluorouracil , Hematologic Neoplasms , Leucovorin , Tumor Lysis Syndrome
7.
Yonsei Medical Journal ; : 797-800, 2013.
Article in English | WPRIM | ID: wpr-211903

ABSTRACT

We report a case of a chronic hemodialysis patient who developed hypermagnesemia due to an overdose of magnesium-containing laxative and paralytic ileus resulting in colonic perforation. Despite intravenous calcium infusion and daily hemodialysis, the patient developed ischemic colitis and intestinal perforation. Colonic perforation accompanied with hypermagnesemia in hemodialysis patients has rarely been reported. This case suggests that hypermagnesemia should be considered in renal failure patients as this can result in life-threatening events despite prompt treatment.


Subject(s)
Female , Humans , Middle Aged , Colitis, Ischemic/chemically induced , Constipation/drug therapy , Intestinal Perforation/chemically induced , Laxatives/adverse effects , Magnesium/poisoning , Renal Dialysis
8.
Yeungnam University Journal of Medicine ; : 196-201, 2011.
Article in Korean | WPRIM | ID: wpr-170826

ABSTRACT

A 73-year-old male presented a six-month history of buttock pain radiating into his thigh. The MRI revealed a large enhancing mass lesion involving the sacrum, with extension into the sacral canal. The tumor markers were measured to distinguish skeletal metastasis of carcinoma from primary bone tumor. The CA 19-9 was elevated. Despite the investigation, the primary site of cancer could not be found. Sacral bone biopsy was done. The pathologic examination revealed necrosis, chronic granulomatous inflammation, and multinucleated giant cells, consistent with tuberculosis. Sacral tuberculosis is rare in patients with no history of tuberculosis. Such solitary osteolytic lesions involving the subarticular region of large joints may mimic bone neoplasms and may be called "tuberculous pseudotumors." This case report intends to emphasize that bone tuberculosis should be a differential diagnosis in the presence of atypical clinical and radiological features. As tuberculous lesions may be mistaken for neoplasms, a small amount of fresh tissue should be sent for culture even if clinical diagnosis of a tumor seems likely. Described herein is a case of sacral tuberculosis mimicking metastatic bone tumor with elevated CA 19-9.


Subject(s)
Aged , Humans , Male , Biopsy , Bone Neoplasms , Buttocks , Diagnosis, Differential , Giant Cells , Hydrazines , Inflammation , Joints , Necrosis , Neoplasm Metastasis , Sacrum , Thigh , Tuberculosis , Tuberculosis, Osteoarticular , Biomarkers, Tumor
SELECTION OF CITATIONS
SEARCH DETAIL